Bristol-Myers Squibb Company (BMY) · page 189 of 197
This is a classic activist investor 'vote no' slide, highlighting valuation discrepancies and execution risk.
Activist deck · thesis_headline · diagnose_problem · overcrowded density
Slide locked Sign in to view
Slide schematic 9/9
callout 1/1 list 4/4 paragraph 1/1 source-note 1/1 title 2/2
Components 9
primary bullet bullet bullet bullet paragraph source-note action-title headline
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 0
∅
No frameworks
No framework match is anchored to this slide.